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Abstract
Background: Cardiac Resynchronization Therapy (CRT) leads to a reduction of left-ventricular
dyssynchrony and an acute and sustained hemodynamic improvement in patients with chronic heart
failure. Furthermore, an optimized AV-delay leads to an improved myocardial performance in
pacemaker patients. The focus of this study is to investigate the acute effect of an optimized AV-
delay on parameters of dyssynchrony in CRT patients.
Method: 11 chronic heart failure patients with CRT who were on stable medication were included
in this study. The optimal AV-delay was defined according to the method of Ismer (mitral inflow
and trans-oesophageal lead). Dyssynchrony was assessed echocardiographically at three different
settings: AVDOPT; AVDOPT-50 ms and AVDOPT+50 ms. Echocardiographic assessment included 2D-
and M-mode echo for the assessment of volumes and hemodynamic parameters (CI, SV) and LVEF
and tissue Doppler echo (strain, strain rate, Tissue Synchronisation Imaging (TSI) and myocardial
velocities in the basal segments)
Results: The AVDOPT in the VDD mode (atrially triggered) was 105.5 ± 38.1 ms and the AVDOPT
in the DDD mode (atrially paced) was 186.9 ± 52.9 ms. Intra-individually, the highest LVEF was
measured at AVDOPT. The LVEF at AVDOPT was significantly higher than in the AVDOPT-50setting (p
= 0.03). However, none of the parameters of dyssynchrony changed significantly in the three
settings.
Conclusion: An optimized AV delay in CRT patients acutely leads to an improved systolic left
ventricular ejection fraction without improving dyssynchrony.
Background
Asynchronous myocardial contraction in heart failure is
associated with poor prognosis. Recent studies have
shown an acute and sustained hemodynamic improve-
ment after biventricular pacing (BVP), reversal of LV-
remodelling, an increased quality of life, a reduction of
symptoms of heart failure, and an improvement of exer-
cise tolerance [1-7].
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The optimization of the AV delay in DDD pacemaker
patients is generally recommended and is performed in
clinical practice. A variety of invasive and non-invasive
methods were assessed in the past [8-15]. Recent studies
have shown that also in CRT patients, invasively (dP/dt)
[16-19] and non-invasively measured hemodynamic
parameters (stroke volume) [20,21] are modified accord-
ing to the programmed AV delay. A hemodynamically
optimal AV delay can be defined.
Ismer's method of AV delay optimization [22] is validated
for biventricular as well as right ventricular DDD pacing.
Tissue Doppler Imaging (TDI) is an evaluated tool in clin-
ical practice to identify myocardial dyssynchrony. TDI
(including strain and strain rate) imaging measures
regional wall motion velocities and can accurately quan-
tify regional left ventricular function [24].
Strain measures compression and distension of myocar-
dial segments ("deformation imaging") and strain rate
imaging expresses strain changes per time interval [25].
TSI (Tissue Synchronization Imaging) utilizes color-coded
time-to-peak tissue Doppler velocities and visualizes seg-
ments of dyssynchrony in real-time by superimposing
these temporal motion data on 2D echo images. [26,27].
These new techniques could potentially improve patient
selection and guidance of implantation and programming
of the devices for BVP. There is a variety of methods to
determine dyssynchrony as summarized elsewhere [28].
There are no published data on the correlation of param-
eters of dyssynchrony and programming of the optimal
AV interval. Aims of our study were therefore to investi-
gate the influence of an optimized AV delay determined
by the method of Ismer et al. [22] on dyssynchrony.
Table 1: Patient characteristics
Age(mean ± SD) 63.2 ± 11.7
Gender (m/f) (n/%) 7(63.6)/4(36.4%)
Coronary artery disease (n/%) 4 (36.4%)
Dilated Cardiomyopathy (n/%) 7 (63.6%)
Left-ventricular ejection fraction (mean ± SD) 27.3% ± 11.9
Interval in months between stress testing and ICD implantation (months) (mean ± SD) 11.9 ± 12.9
location of the CS – electrode
lateral 6 (54%)
posterolateral 4 (36.4%)
anterolateral 1 (9%)
diabetes mellitus (n/%) 6 (54%)
medication
ACE inhibitors (n/%) 9 (82%)
ARB (n/%) 2 (18%)
Beta-blockers (n/%) 10 (91%)
Digitalis (n/%) 8 (73%)
Diuretics (n/%) 11 (100%)
spironolactone (n/%) 8 (73%)
ARB = Angiotensin-receptor blockers;
CS = coronary sinus
Table 2: Measurement of the components of the optimal AV delay according to Ismer et al. [22]
pacemaker-related interatrial conduction interval (IACT) VDD pacing: MA-LA measured between right-atrial sense-event marker 
(MA) and the beginning of left-atrial deflection (LA) in oesophageal 
electrogram
DDD pacing: SA-LA measured between right-atrial pacing stimulus (SA) 
and the beginning of left-atrial deflection (LA) in oesophageal 
electrogram
left-atrial electromechanical action (LA-EAClong) Measured during unphysiologically long programmed AV delay between 
the beginning of left-atrial deflection (LA) in oesophageal electrogram 
and the end of the left-atrial contribution (EAC) in transmitral flow.
left-ventricular electromechanical latency period (Sv-EACshort) Measured during unphysiologically short programmed AV delay between 
ventricular pacing stimulus (Sv) and the end of the left-atrial contribution 
(EAC) in transmitral flow.Cardiovascular Ultrasound 2006, 4:5 http://www.cardiovascularultrasound.com/content/4/1/5
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Methods
Patients
11 chronic heart failure patients of our clinic were
included in this study. All patients had a biventricular ICD
(pre-implantation NYHA III-IV, EF < 35%, QRS width >
120 ms). Clinical characteristics are demonstrated in
Table 1. Patient exclusion criteria were as follows: atrial
fibrillation, pacemaker malfunction and oesophageal dis-
eases, NYHA IV, prosthetic mitral valve replacement.
AV delay: components and optimization
For the AV delay optimization we used the method pro-
posed by Ismer et al [22].
This approach needs the placement of a bi-polar oesopha-
geal electrode to provide a filtered left-atrial electrogram
(LAE). We applied a 5F oesophagus electrode (Osypka
TO2/5F, order no. TA12991101, Rheinfelden, Germany).
Filtered oesophageal electrogram and telemetric real-time
pacemaker markers provided by the programmer's ana-
logue output were superimposed on the display of trans-
mitral flow velocity on the Doppler-echo system (Figure
1). The simultaneous recording of transmitral flow, the
left atrial oesophageal electrogram and the real-time
sense-event markers, allow determining the components
of the optimal AV delay (Table 2, Figure 1 and 2).
Based on these measurements, optimal AV delays were
calculated for VDD (atrial-triggered) and DDD (atrial-
paced) mode using the equations:
AVDOPT VDD = MA-LA + LA-EAClong - Sv-EACshort
and
AVDOPT DDD = SA-LA + LA-EAClong - Sv-EACshort
Echocardiograhy
Echocardiography to assess dyssynchrony was performed
subsequently under three pacemaker settings: optimal AV
delay (AVDOPT), optimal AV delay minus 50 ms (AVDOPT-
50), optimal AV delay plus 50 ms (AVDOPT+50).
Echocardiography was performed on the Vivid 5 and
Vivid 7 Dimension (GE Vingmed Ultrasound, Horton,
Norway) machines. The TDI and strain analysis were per-
formed in an off-line work station. The LVEF was assessed
by area-length method in the apical four chamber view.
The CI and the SV were calculated from the systolic veloc-
ities measured by PW-Doppler in the aortic outflow tract.
Strain rate, tissue Doppler velocities were measured in the
basal segments of the apical four-, three- and two-cham-
ber views.
Statistics
Values are expressed as mean ± standard deviation (SD).
Groups were compared by parametric or non-parametric
tests (t-tests and Wilcoxon-Mann-Whitney tests, respec-
tively). Statistical significance was assumed at a value of P
< 0.05. Statistical analysis was performed with the SPSS 12
software package (SPSS; Chicago, Ill, USA).
Results
Optimal AV delay
In all patients, we could define an optimal AV delay in the
VDD and the DDD modes respectively. The AVDOPT in
VDD mode was 105.5 ± 38.1 ms and the AVDOPT in the
DDD pacing mode was 186.9 ± 52.9 ms. The results are
summarized in Table 3. As expected, the mean optimal AV
delay was lower in the VDD than in the DDD mode.
Assessment of the left-atrial electromechanical action = LA- EAClong Figure 2
Assessment of the left-atrial electromechanical action = LA-
EAClong. LA = left atrial deflection (see oesophagus- ECG). 
EAClong = the end of the A-wave in an unphysiologically long 
AV-intervall. In this particular patient the LA-EAClang is 160 
ms
Measurement of the IACT in the VDD - Mode = MA-LA Figure 1
Measurement of the IACT in the VDD - Mode = MA-LA. MA 
= right atrial sensing marker (see marker channel). LA = left 
atrial deflection (see oesophageal ECG). In this particular 
patient the IACT is 48 ms.Cardiovascular Ultrasound 2006, 4:5 http://www.cardiovascularultrasound.com/content/4/1/5
Page 4 of 6
(page number not for citation purposes)
Echocardiography was performed subsequently under
three pacemaker settings: AVDOPT, AVDOPT-50,
AVDOPT+50. All patients had continuous biventricular
stimulation even under AVDOPT+50.
2D and TDI echocardiography
The LVEF with AVDOPT  was 28% (± 12%), with an
AVDOPT-50 20% (± 7%, p= 0.03 compared to AVDOPT),
with an AVDOPT+50 23% (± 7%, p = 0.11 compared to
AVDOPT). The heart rate did not change significantly in the
different settings (AVDOPT: 65,4/min, AVDOPT-50: 65,6/
min, AVDOPT+50: 65,8 ms). The hemodynamics (SVI, CI,
LVEF) and the TDI derived data are listed in Table 4. There
was no significant difference of the amount of segments
with dyssynchrony in TSI in the three settings. The maxi-
mal delay in the basal segments in the apical two-, three-
and four-chamber views measured by TSI and strain did
not differ in the AVDOPT, AVDOPT+50 and AVDOPT-50 set-
ting.
Discussion
Optimal AV delay
To date, Ismer's method for the optimal AV delay was
applied to patients with DDD pacemakers and normal left
ventricular function [22,23]. This is the first study to
assess the optimal AV delay by Ismer's method in patients
with reduced left ventricular function. In our CRT
patients, an optimal AV delay according to Ismer's
method could be defined. This is the only method that
allows separate measurement of the three AV-delay com-
ponents: i.e., the pacemaker-related interatrial conduction
time, the left-atrial electromechanical action, and the left-
ventricular latency period. The benefits of this method,
however, are offset by the necessity for placement of an
oesophageal electrode. This requirement explains why
only a few medical centres have applied this method in
clinical practice and in most cases for purposes of scien-
tific investigation only.
Our results concerning the AVDOPT in the VDD mode
(105.5 ± 38.1 ms) are in agreement with the results of
other studies on AVDOPT in CRT patients: Butter [16]
determined an AVDOPT of 100 ms in 30 patients, Auric-
chio [17] an AVDOPT of 112 ± 33 ms in 41 patients and
Kass [18] an AVDOPT of 125 ± 49 ms. A study that was
recently published by Porciani [29] found an AVDOPT dur-
ing simultaneous biventricular pacing of 97 + 27 ms.
In the literature, there are no published data on AVDOPT in
DDD mode. Therefore, our AVDOPT in DDD mode of
186.9 ± 52.9 ms cannot be compared to other studies.
Table 4: Hemodynamic and Tissue Doppler Echocardiography parameters in the AVDOPT, AVDOPT-50 and AVDOPT+50 modes.
Hemodynamics
AVDOPT AVDOPT-50 AVDOPT+50 p
SV [ml] 89,2 (± 27.7) 89,7 (± 36.9) 95,3 (± 36.9) n.s.
LVEF 0,28 (± 0.12) 0,20 (± 0.07)* 0,23 (± 0.07)** *0.03 / **0.11
CI 3,0 (± 0.9) 3,2 (± 0.8) 3,4 (± 0.9) n.s.
HR 65,4 (± 8.8) 65,6 (± 9.4) 65,8 (± 9.4) n.s.
Tissue Doppler
AVDOPT AVDOPT-50 AVDOPT+50 p
TDI max. delay in basal segments [ms] 122,9 (± 95,6) 125,0 (± 109,2) 131,7 (± 85,2) n.s.
TSI segments with asynchrony 2,08 (± 1,24) 2,27 (± 1.19) 2,41 (± 1.43) n.s.
Strain max. delay in basal segments [ms] 148,3 (± 74.9) 167,5 (± 90.2) 151,7 (± 54.1) n.s.
Strain [%]
4AC lateral 13,7 (± 6,5) 14.5 (± 9.8) 13,4 (± 9.8) n.s.
4 AC septal 15,6 (± 7,3) 13.9 (± 9.3) 15.0 (± 9.8) n.s.
A2C anterior 16,8 (± 9,7) 17.2 (± 10.5) 16.1 (± 9.1) n.s.
A2C inferior 20,0 (± 11,5) 15.0 (± 11.4) 16.1 (± 9.8) n.s.
A3C anterior 19,7 (± 9,5) 12.4 (± 9.7) 18.1 (± 9.8) n.s.
A3C interior 19,1 (± 9,8) 14.1 (± 12.7) 19.2 (± 10.1) n.s.
Table 3: AVDOPT VDD = optimal AV delay for atrially triggered 
(VDD) and atrially paced (DDD) modes
patient AVDOPT VDD AVDOPT DDD
16 0 1 7 2
27 8 1 5 4
39 6 2 0 4
49 2 1 3 2
59 2 1 4 4
61 2 2 1 7 4
71 3 6 2 1 6
86 4 1 2 8
98 4 1 8 0
10 168 252
11 168 300
105,5 ± 38,1 ms 186,9 ± 52,9 ms
ARB = Angiotensin-receptor blockers; CS = coronary sinusCardiovascular Ultrasound 2006, 4:5 http://www.cardiovascularultrasound.com/content/4/1/5
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Hemodynamics
Intra-individually, the patients had the best LVEF under
optimal AV-delay compared to the +50 and -50 ms set-
tings. The LVEF is significantly higher in the AVDOPT set-
ting than in the AVDOPT  -50 setting. Obviously the
formation of "cannon waves" seen with a shorter AV inter-
val (AVDOPT -50) had a more negative hemodynamic
effect than the diastolic mitral regurgitation seen with
longer AV delays (AVDOPT +50). The hemodynamically
unfavourable effects of "cannon waves" are described
since the beginning of pacemaker therapy and are also
termed "pacemaker syndrome". It is generally accepted
that an adequate pacemaker programming can avoid this
[30]. Toda et al. [31] could show in his studies that the
mean LVEF in AVDOPT is higher than in prolonged AV
delays. However, he found no significant difference.
Dyssynchrony
Changes of dyssynchrony can be seen immediately, as
seen in studies that have examined on/off comparisons in
CRT patients [32]. However, an optimized AV interval
does not change the markers of dyssynchrony. The reason
for the improved hemodynamic situation under AVDOPT
seems to be the better left ventricular filling and not the
altered dyssynchrony.
Limitations
This study included only a small number of patients.
There was no follow-up examination of the patients.
Conclusion
This study confirmed that an optimized AV delay
improves the left ventricular ejection fraction. Acutely, the
optimized AV delay does not influence left ventricular
dyssynchrony. Whether a long-term AVDOPT  leads to
changes in left ventricular dyssynchrony via an improved
LVEF and reverse remodelling can only be speculated. This
has to be addressed in future studies with a long-term
observation interval.
Abbreviations
AVDOPT optimal AV delay
AVDOPT-50 optimal AV delay -50 ms
AVDOPT+50 optimal AV delay + 50 ms
CRT Cardiac Resynchronization Therapy
DCM Dilated Cardiomyopathy
EMD Electromechanical Delay
IVMD Inter-ventricular mechanical delay
LBBB Left Bundle Branch Block
SRI strain rate imaging
TDI Tissue Doppler Imaging
TSI Tissue Synchronization Imaging
VDD atrially triggered mode
DDD atrailly paced mode
EAC the end of the A-wave
LVEF Left ventricular ejection fraction
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